Chapter 1: The Enigma of Cancer Cell Dormancy

Cancer cells have a remarkable ability to mimic hibernation, allowing them to dodge chemotherapy. This phenomenon leads to the emergence of drug-tolerant persisters (DTPs), which can survive aggressive treatments.

Recent findings suggest that cancer cells could be engaging in behaviors akin to those of hibernating animals. This insight may clarify why the disease often recurs in patients who initially seem to have overcome it. As someone who has witnessed these challenges, I understand why those who conquer cancer through conventional therapies are often labeled as 'ticking time bombs'—a label that reflects the uncertainty in declaring someone "cured."

Although the emergence of drug-resistant ‘superbugs’ is well-documented, the same concept was not widely associated with cancer until recently. A study conducted by the University Health Network in Canada, which encompasses five cancer research institutes, proposes that all cancer cells might possess the ability to enter dormancy as a means of survival against chemotherapy.

This research could significantly contribute to finding effective long-term solutions for cancer survivors. While it is promising to explore alternative treatments such as vaccines, addressing the risk of recurrence is equally critical. The mechanisms being studied mirror those of animals in hibernation.

“We never actually knew that cancer cells were like hibernating bears. This study also tells us how to target these sleeping bears so they don’t hibernate and wake up to come back later, unexpectedly.”

~ Aaron Schimmer, Lead Researcher

Chapter 2: Chemotherapy and Its Challenges

For those unfamiliar, chemotherapy is the primary aggressive treatment for cancer, often accompanied by severe side effects. Despite advancements in medical technology and research, this invasive approach remains prevalent, particularly for patients deemed healthy enough to withstand it. Those who are frail often cannot endure such harsh regimens.

With this newfound understanding, researchers are optimistic about their ability to target cancer cells before they acquire the genetic mutations that lead to drug resistance. Additionally, they can focus on dormant cancer cells, which may be the crucial element oncologists have sought in their quest to understand cancer recurrence.

The study specifically examined human colorectal cancer cells. The findings indicated that chemotherapy could induce a slow-dividing state in these cells, similar to the hibernation-like embryonic diapause observed in mouse embryos. This state allows embryos to pause development under adverse conditions until circumstances improve for survival.

Many species can undergo this embryonic diapause through a cellular process known as autophagy. The current research indicates that cancer cells utilize this same mechanism to evade aggressive treatments. The encouraging news is that inhibiting autophagy could enable chemotherapy to effectively kill these cancer cells before they transition into dormancy.

The research team designated these dormant cells as “drug-tolerant persisters” (DTPs), and their model suggests that all cancer cells have the potential to become DTPs. This discovery may lead to more effective cancer treatments and minimize the risk of recurrence.

Complete Research was published in the Journal of Cell.

Stay informed with the content that matters — Join my mailing list.